| Literature DB >> 25470234 |
Shane Deegan1, Svetlana Saveljeva, Susan E Logue, Karolina Pakos-Zebrucka, Sanjeev Gupta, Peter Vandenabeele, Mathieu J M Bertrand, Afshin Samali.
Abstract
Endoplasmic reticulum (ER) stress-induced cell death is normally associated with activation of the mitochondrial apoptotic pathway, which is characterized by CYCS (cytochrome c, somatic) release, apoptosome formation, and caspase activation, resulting in cell death. In this study, we demonstrate that under conditions of ER stress cells devoid of CASP9/caspase-9 or BAX and BAK1, and therefore defective in the mitochondrial apoptotic pathway, still undergo a delayed form of cell death associated with the activation of caspases, therefore revealing the existence of an alternative stress-induced caspase activation pathway. We identified CASP8/caspase-8 as the apical protease in this caspase cascade, and found that knockdown of either of the key autophagic genes, ATG5 or ATG7, impacted on CASP8 activation and cell death induction, highlighting the crucial role of autophagy in the activation of this novel ER stress-induced death pathway. In line with this, we identified a protein complex composed of ATG5, FADD, and pro-CASP8 whose assembly coincides with caspase activation and cell death induction. Together, our results reveal the toxic potential of autophagy in cells undergoing ER stress that are defective in the mitochondrial apoptotic pathway, and suggest a model in which the autophagosome functions as a platform facilitating pro-CASP8 activation. Chemoresistance, a common problem in the treatment of cancer, is frequently caused by the downregulation of key mitochondrial death effector proteins. Alternate stress-induced apoptotic pathways, such as the one described here, may become of particular relevance for tackling the problem of chemoresistance in cancer cells.Entities:
Keywords: ATG, autophagy related; BAK1, BCL2-antagonist/killer 1; BAX, BCL2-associated X protein; BCL2, B-cell CLL/lymphoma 2; DDIT3, DNA-damage-inducible transcript 3; DISC, death inducing signaling complex; DTT, dithiothreitol; ER, endoplasmic reticulum; FADD, Fas (TNFRSF6)-associated via death domain; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HSPA5, heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa); MAP1LC3 (LC3), microtubule-associated protein 1 light chain 3; MEFs, mouse embryonic fibroblasts; MOMP, mitochondrial outer membrane permeabilization; PARP, poly (ADP-ribose) polymerase; PBS, phosphate-buffered saline; PI, propidium iodide; TNF, tumor necrosis factor; TNFSF10, tumor necrosis factor (ligand) superfamily, member 10; Tg, thapsigargin; Tm, tunicamycin; apoptosis; autophagic cell death; autophagy; caspase; endoplasmic reticulum stress; unfolded protein response
Mesh:
Substances:
Year: 2014 PMID: 25470234 PMCID: PMC4502706 DOI: 10.4161/15548627.2014.981790
Source DB: PubMed Journal: Autophagy ISSN: 1554-8627 Impact factor: 16.016
Figure 1.Apoptosome-compromised cells undergo ER stress and cell death in response to ER stress-inducing agents. Casp9+/+ and casp9−/− MEFs were treated with (A) 0.5 μM of Tg or (B) 0.5 μg/ml of Tm for the indicated times and lysates immunoblotted for expression of ER stress markers HSPA5, EIF2AK3 and DDIT3. (C) Representative phase contrast images of Casp9+/+ and casp9−/− cells as treated in (A) and (B). (D and E) Casp9+/+ and casp9−/− MEFs were treated with (D) 0.5 μM of Tg or (E) 0.5 μg/ml of Tm for the indicated times followed by analysis of propidium iodide (PtdIns) uptake at the indicated time points. Results are representative of at least 3 independent experiments. Error bars represent the mean ± SD.
Figure 2.ER stress-induced cell death in apoptosome-compromised cells is accompanied by caspase activation. (A and B) Casp9+/+ and casp9−/− MEFs were treated for the indicated times with (A) 0.5 μM Tg or (B) 0.5 μg/ml of Tm and lysates immunoblotted for CASP9, CASP3, PARP, and actin. (C) Bax+/+ and bax−/− MEFs were treated with 1 μg/mL of Tm for indicated timepoints. Cell viability was analyzed by PI uptake. (D) Bax+/+ and bax−/− MEFs were treated with 1 μg/ml of Tm for the indicated times and lysates were immunoblotted for CASP9, CASP3, PARP and tubulin. (E) Bax+/+ and bax−/− MEFs were treated with 1 μg/ml of Tm for indicated times and CASP3-like activity was determined by DEVD-AMC hydrolysis. Results are representative of at least 3 independent experiments. Error bars represent the mean ± SD. (G) casp9−/− MEFs were treated with 0.5 μM Tg with or without Boc-D-FMK for the indicated times and lysates immunoblotted for PARP and cleaved CASP3. (H and I) casp9−/− MEFs were treated with (H) 0.5 μM Tg or (I) 0.5 μg/ml of Tm for the indicated times and lysates immunoblotted for cleaved CASP8.
Figure 3.Knockdown of Casp8 prevents ER stress-induced CASP3 activation and reduces cell death upon exposure to sustained ER stress in apoptosome-compromised cells. casp9−/− MEFs were stably transduced with pLKO or Casp8 shRNA lentivirus. ((A)and B) pLKO and Casp8 shRNA casp9−/− MEFs were treated for the indicated times with 0.5 μM Tg (A) or 0.5 μg/ml of Tm (B) and lysates immunoblotted for pro-CASP8, cleaved CASP3 and actin. ((C)and D) pLKO and Casp8 shRNA casp9−/− MEFs were treated with 0.5 μM Tg (C) or 0.5 μg/ml of Tm (D) for the indicated times and cell viability analyzed by propidium iodide (PtdIns) uptake. (E) pLKO and Casp8 shRNA casp9−/− MEFs were treated for 72 h with 0.5 μg/mL of Tm alone or in combination with 20 μM of Boc-D-FMK. Treatment was washed off and allowed to form colonies for 10 d. Boc-D-FMK was replenished for first 3 d of the recovery. Colonies were stained with crystal violet and pictures taken (F) pLKO and Casp8 shRNA casp9−/− MEFs were treated with 0.5 μM 1 μg/mL of Tm for 72 h. Cytochrome c release was analyzed by quantifying loss of FITC staining by flow cytometry. Results are representative of at least 3 independent experiments. Error bars represent the mean ± SD.
Figure 4.Role of death receptor signaling in ER stress-induced cell death. (A and B) casp9−/− MEFs were pretreated with 50 ng/mL of TNF blocking antibody, 100 ng/mL of FAS:Fc or 500 ng/mL of TNFS10 blocking antibody for 1 h. For the next 24 h cells were treated with 0.5 μM of Tg (C) or 0.5 μg/ml Tm (D) and cell death estimated by propidium iodide staining. Protein samples from the same treatments were also harvested and expression of cleaved CASP8 was evaluated by protein gel blot (E). Actin was used as a loading control. Results are representative of at least 3 independent experiments. Error bars represent the mean ± SD.
Figure 5.ER stress-induced cell death in apoptosome-compromised cells is associated with the induction of autophagy. (A) Casp9+/+ and casp9−/− MEFs were transiently transfected with GFP-LC3-expressing plasmid, treated with 0.5 μM Tg (24 h post-transfection) and analyzed at the indicated times for LC3-GFP puncta. Representative fluorescent images are shown. ((B)and C) Casp9+/+ and casp9−/− MEFs were treated with (B) 0.5 μM Tg or (C) 0.5 μg/ml of Tm for the indicated times and lysates immunoblotted for LC3-I to LC3-II conversion. (D-E) Casp9+/+ or casp9−/− MEFs were treated with 20 μM chloroquine alone, 0.5 μg/ml Tm alone, or a combination of 20 μM chloroquine and 0.5 μg/ml of Tm for the indicated times and cell lysates immunoblotted for LC3-I and LC3-II and actin. Results are representative of at least 3 independent experiments. Error bars represent the mean ± SD.
Figure 6 See previous page.Inhibition of autophagy reduces caspase activation and cell death in apoptosome-compromised cells exposed to sustained ER stress. casp9−/− MEFs stably expressing pGIPZ or Atg5 shRNA were generated and treated for the indicated times with (A) 0.5 μM Tg or (B) 0.5 μg/ml of Tm after which lysates were assessed by immunoblotting for ATG5, cleaved CASP8, cleaved CASP3 and actin. (C) Atg5 shRNA and pGIPZ casp9−/− MEFs were treated for the indicated times with Tg after which cells were fixed and stained with H&E. Representative images are shown. (D) casp9−/− MEFs stably expressing pGIPZ or Atg5 shRNA were treated with 0.5 μg/ml of Tm for 72 h. Treatment was washed off and allowed to form colonies for 10 d. Colonies were stained with crystal violet and pictures taken. (E-F) casp9−/− Atg5 shRNA and casp9−/− pGIPZ MEFs were treated for the indicated times with (E) 0.5 μM Tg or (F) 0.5 μg/ml of Tm and cell viability analyzed by propidium iodide (PI) uptake. (G) pLKO and Atg7 shRNA casp9−/− MEFs were treated for the indicated times with 0.5 μg/ml of Tm, cell lysates prepared and immunoblotted for cleaved CASP8, cleaved CASP3 and actin. (H) pLKO and Atg7 shRNA casp9−/− MEFs were treated for the indicated times with 0.5 μg/ml of Tm and cell viability analyzed by propidium iodide (PtdIns) uptake. Results are representative of at least 3 independent experiments. Error bars represent the mean ± SD.
Figure 7.Knockdown of Fadd reduces ER stress-induced CASP8 activation and cell death apoptosome-compromised cells upon sustained ER stress. casp9−/− MEFs stably expressing pLKO or Fadd shRNA were generated via lentiviral transduction. (A) pLKO and Fadd shRNA casp9−/− MEFs were treated with TNF alone (100 ng/ml), cycloheximide alone (1 μg/mL) or a combination of TNF and cycloheximide for 24 h after which cell viability was analyzed by propidium iodide (PI) uptake. Results are representative of at least 3 independent experiments. Error bars represent the mean ± SD. ((B)and C) casp9−/− MEFs stably expressing pLKO or Fadd shRNA were treated for the indicated times with (B) 0.5 μM Tg or (C) 0.5 μg/ml Tm, cell lysates prepared and immunoblotted for cleaved CASP8, cleaved CASP3, FADD and actin. (D and E) casp9−/− MEFs stably expressing pLKO or Fadd shRNA were treated for the indicated times with (D) 0.5 μM Tg or (E) 0.5 μg/ml of Tm and cell viability analyzed by propidium iodide (PtdIns) uptake. Results are representative of at least 3 independent experiments. Error bars represent the mean ± SD.
Figure 8.Pro-CASP8 is recruited to a novel complex comprising of ATG5 and FADD in apoptosome-compromised cells exposed to sustained ER stress. casp9−/− MEFs were treated with a combination of 0.5 μg/ml of Tm for 72 h with 20 μM of Boc-D-FMK added for the last 48 h followed by immunoprecipitation with (A) a control IgG antibody or antibody specific for ATG5 or (B) a control IgG antibody or antibody specific for FADD. Immune complexes were analyzed by immunoblotting for ATG5, FADD, and pro-CASP8. IgG heavy chain band is marked as *. (C) bax−/− MEFs were treated with a combination of 0.5 μM of Tg for 48 h with 20 μM of Boc-D-FMK added for the last 24 h followed by immunoprecipitation with a control IgG antibody or antibody specific for FADD. Immune complexes were analyzed by immunoblotting for ATG5, FADD, and pro-CASP8. Results are representative of at least 3 independent experiments. Error bars represent the mean ± SD.